Sign in

CIK 0001933414 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Mineralys Therapeutics, Inc.

Sign in to watch
Ticker
MLYS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Entity type
operating
EIN
841966887
Phone
(888) 378-6240
Business address
150 N. RADNOR CHESTER ROAD, SUITE F200, RADNOR, PA
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$5,403,032
in 5 filings, $2.4M under 10b5-1 plans

Net −$5,403,032. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Slingsby Brian Taylor −$3.0M Director sold 1% of stake
  2. Congleton Jon −$1.9M Chief Executive Officer sold 12% of stake
  3. Warren Eric −$402K Chief Commercial Officer sold 28% of stake
  4. Karydas Daphne −$86K Director sold 33% of stake

Reading 62 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-02-19 Karydas Daphne Director Grant or award · Stock Option +8,300 8,300
2026-02-19 Slingsby Brian Taylor Director Grant or award +6,200 6,200
2026-02-19 Slingsby Brian Taylor Director Other disposition −6,200 0
2026-02-19 Slingsby Brian Taylor Director Other acquisition +6,200 7,910,038
2026-02-19 Slingsby Brian Taylor Director Grant or award · Stock Option +8,300 8,300
2026-02-19 Slingsby Brian Taylor Director Other disposition · Stock Option −8,300 0
2026-02-19 Slingsby Brian Taylor Director Other acquisition · Stock Option +8,300 8,300
2026-02-19 AKKARAJU SRINIVAS Director Grant or award +6,200 6,200
2026-02-19 AKKARAJU SRINIVAS Director Grant or award · Stock Option +8,300 8,300
2026-02-19 DiRocco Derek Director Grant or award +6,200 6,200
2026-02-19 DiRocco Derek Director Grant or award · Stock Option +8,300 8,300
2026-02-19 Rodman David Malcom Chief Medical Officer Grant or award +38,400 82,489
2026-02-19 Rodman David Malcom Chief Medical Officer Grant or award · Stock Option +51,300 51,300
2026-02-19 Levy Adam Scott CFO and Secretary Grant or award +39,900 48,538
2026-02-19 Levy Adam Scott CFO and Secretary Grant or award · Stock Option +53,300 53,300
2026-02-19 RA CAPITAL MANAGEMENT, L.P. Director Grant or award +6,200 6,200
2026-02-19 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Stock Option (Right to Buy) +8,300 8,300
2026-02-17 Rodman David Malcom Chief Medical Officer Option exercise 10b5-1 +417 $15.44 $6K 44,506
2026-02-17 Rodman David Malcom Chief Medical Officer Sale 10b5-1 −417 $27.59 $12K 44,089
2026-02-17 Rodman David Malcom Chief Medical Officer Option exercise · Stock Option 10b5-1 −417 5,417

Page 7 of 17 · 321 trades